Patent 7893196 was granted and assigned to Novozymes on February, 2011 by the United States Patent and Trademark Office.
The present invention relates to isolated polypeptides having antimicrobial activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.